1. A sustained release tablet containing theobromine, consisting of a sustained release layer and a quick release layer, wherein the sustained release layer consists of 40-60 wt.% Of theobromine or its salts, 14-19 wt.% Of a sustained release base consisting of polyethylene oxide and hydroxypropylmethyl cellulose, 1-2 wt.% a binding agent and 0.5-1 wt.% slip modifier, where the quick release layer consists of 10-30 wt.% of theobromine or its salts, 0.5-2 wt.% of a disintegrant, consisting from one or more their components selected from croscarmellose sodium, crospovidone and the sodium salt of starch glycolate, 0.3-1.5 wt.% binding agent and 0.1-0.5 wt.% slip modifier. 2. A sustained release tablet according to claim 1, wherein the content of theobromine or its salts in the sustained release layer and in the rapid release layer total 300 mg or 600 mg. A sustained release tablet according to claim 1 or 2, wherein the sustained release base comprises from 6 to 10 wt.% Polyethylene oxide with a molecular weight of 900,000-1000000 and from 8 to 12 wt.% Hydroxypropylmethyl cellulose with a viscosity of 4000 cps. 4. The sustained-release tablet according to claim 1 or 2, wherein the extended-release layer and the quick-release layer are formed from two-layer structures layered both up and down, or a three-layer structure, which has an upper and lower layer, which are quick-release layers, and a sustained release layer is in between.1. Таблетка пролонгированного высвобождения, содержащая теобромин, состоящая из слоя пролонгированного высвобождения и слоя быстрого высвобождения,где слой пролонгированного высвобождения состоит из 40-60 мас.% теобромина или его солей, 14-19 мас.% основы пролонгированного высвобождения, состоящей из полиэтиленоксида и гидроксипропилметилцеллюлозы, 1-2 мас.% связующего агента и 0,5-1 мас.% модификатора скольжения,где слой быстрого высвобождения состоит из 10-30 мас.% теобромина или его солей, 0,5-2 мас.% разрыхлителя, состоящего из одного или н
